Acquired resistance to TKIs in solid tumours: learning from lung cancer

DR Camidge, W Pao, LV Sequist - Nature reviews Clinical oncology, 2014 - nature.com
… The very broad range of tyrosine kinase target mutations seen in ALK-rearranged lung cancer
with acquired resistance to crizotinib is reminiscent of the variety of resistance mutations to …

Acquired resistance in lung cancer

A Tulpule, TG Bivona - Annual Review of Cancer Biology, 2020 - annualreviews.org
… We consider the multifaceted resistance mechanisms tumors utilize, often simultaneously. …
acquired resistance, as it remains the major scientific and clinical challenge in lung cancer. …

New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer

GR Oxnard, ME Arcila, J Chmielecki, M Ladanyi… - Clinical cancer …, 2011 - AACR
… Several possible mechanisms for acquired resistance have been … of acquired TKI resistance
in EGFR-mutant lung cancer and review … Clin Cancer Res; 17(17); 5530–7. ©2011 AACR. …

Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategies

SM Lim, NL Syn, BC Cho, RA Soo - Cancer treatment reviews, 2018 - Elsevier
… , acquired resistance is ubiquitous and remains a key challenge. Investigations into the
mechanisms which foster resistance … -small cell lung cancer patients with acquired resistance to …

[HTML][HTML] Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer

AJ Schoenfeld, SJ Antonia, MM Awad, E Felip… - Annals of …, 2021 - Elsevier
… in classification of acquired resistance that require urgent … lung cancer treatment with
unprecedented durability of responses in patients with advanced disease, but acquired resistance (…

[HTML][HTML] Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

SG Wu, JY Shih - Molecular cancer, 2018 - Springer
lung cancer develop disease progression after a median of 10 to 14 months on EGFR TKI.
Different mechanisms of acquired resistance to … mechanisms of acquired resistance is not yet …

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer

JA Engelman, PA Jänne - Clinical Cancer Research, 2008 - AACR
Acquired resistance mechanisms have been studied most extensively in EGFR mutant
cancers … It remains to be determined if these resistance mechanisms are shared with wild-type …

Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny

K Suda, H Mizuuchi, Y Maehara… - Cancer and Metastasis …, 2012 - Springer
… Diversity and ductility in acquiring resistance to TKIs in EGFR-mutated lung cancers. HCC827
lung cancer cells, shown here, are frequently used as in vitro acquired resistance models; …

[HTML][HTML] Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy

L Boyero, A Sánchez-Gastaldo, M Alonso… - Cancers, 2020 - mdpi.com
… Here, we summarized the impact of immunotherapy on lung cancer … and acquired resistance
to immunotherapy in this disease. … in lung cancer, with a focus on the underlying resistance

[HTML][HTML] Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non–small-cell lung cancer

D Jackman, W Pao, GJ Riely, JA Engelman… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
acquire resistance to either drug. Currently, the clinical definition of such secondary or
acquired resistance … be used to define more precisely acquired resistance to EGFR TKIs. All …